(Q43692301)

25 November 2017

title

Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research (English)

1 reference

25 November 2017

1 reference

Armando L Morera

1

1 reference

25 November 2017

Aintzane Intxausti

series ordinal

2

1 reference

25 November 2017

Pedro Abreu-Gonzalez

series ordinal

3

1 reference

25 November 2017

publication date

1 January 2009

1 reference

World Journal of Biological Psychiatry

25 November 2017

published in

1 reference

25 November 2017

volume

10

1 reference

25 November 2017

issue

4 Pt 2

1 reference

25 November 2017

page(s)

576-580

1 reference

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Decrease of serum malondialdehyde in patients treated with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Factors associated with oxidative stress in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Antioxidants in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Free radical pathology in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

A review of the evidence supporting melatonin's role as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Antioxidative and steroid systems in neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Melatonin effect on renal oxidative stress under constant light exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Seasonality in biochemical determinations: A source of variance and a clue to the temporal incidence of affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Seasonality of psychopathology and circannual melatonin rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

Daytime/night-time and summer/winter melatonin and malondialdehyde rhythms: an inverse relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801901802

10.1080/15622970801901802

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference